Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06181994Recruiting

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Role: collaborator

NCT03429127Unknown

Normal Saline Vrs Balanced i.v. Fluids in Neurosurgery

Role: collaborator

NCT03795649Not ApplicableUnknown

The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty

Role: lead

NCT01587846Phase 3Unknown

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children

Role: lead

NCT01478217Completed

PEEP Recruitment-comparison Between Ultrasonographic Assessment and LIP Assessment

Role: lead

All 5 trials loaded